Developmental origin of pre-DC2

Human Immunology

Volumn 63, Issue 12, 2002, Pages 1072-1080

  Blom, Bianca ^a   Ligthart, Suzanne J W C ^a   Schotte, Remko ^a   Spits, Hergen ^a  

^a Division of Immunology   (Netherlands)

Author keywords

(Pre )DC2; CD34; Differentiation; FLT3 L; Thymus

Indexed keywords

ALPHA INTERFERON; CD34 ANTIGEN; FLT3 LIGAND; HELIX LOOP HELIX PROTEIN;

ARTICLE; CELL ISOLATION; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; STEM CELL; THYMUS;

ANIMALS; ANTIGENS, CD2; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL LINEAGE; DENDRITIC CELLS; FETAL BLOOD; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIETIC STEM CELLS; HUMANS; THYMUS GLAND;

EID: 0036921732     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00745-0     Document Type: Article

References (76)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 18:767, 2000.
2. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245, 1998.
3. Lennert K, Kaiserling E, Muller-Hermelink HK: Letter: T-associated plasma-cells. Lancet 1:1031, 1975.
4. Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nature Rev Immunol 2:151, 2002.
5. Caux C, Massacrier C, Vanbervliet B, Dubois B, Durand I, Cella M, Lanzavecchia A, Banchereau J: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90:1458, 1997.
6. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GMCSF+TNF alpha. J Exp Med 184:695, 1996.
7. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC: Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27:431, 1997.
8. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994.
9. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109, 1994.
10. Ito T, Inaba M, Inaba K, Toki J, Sogo S, Iguchi T, Adachi Y, Yamaguchi K, Amakawa R, Valladeau J, Saeland S, Fukuhara S, Ikehara S: A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 163:1409, 1999.
11. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S: Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621, 2002.
12. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183, 1999.
13. Blom B, Ho S, Antonenko S, Liu YJ: Generation of interferon alpha-producing predendritic cell (pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 192:1785, 2000.
14. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185:1101, 1997.
15. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835, 1999.
16. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F: Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 94:12551, 1997.
17. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J: BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165:6037, 2000.
18. Kadowaki N, Antonenko S, Lau JY, Liu YJ: Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192:219, 2000.
19. Cella M, Facchetti F, Lanzavecchia A, Colonna M: Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1:305, 2000.
20. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919, 1999.
21. Jefford M, Maraskovsky E, Cebon J, Davis ID: The use of dendritic cells in cancer therapy. Lancet Oncol 2:343, 2001.
22. Zitvogel L, Angevin E, Tursz T: Dendritic cell-based immunotherapy of cancer. Ann Oncol 11(Suppl. 3):199, 2000.
23. Liu YJ, Blom B: Introduction: TH2-inducing DC2 for immunotherapy. Blood 95:2482, 2000.
24. Vremec D, Zorbas M, Scollay R, Saunders DJ, Ardavin CF, Wu L, Shortman K: The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med 176:47, 1992.
25. Matsuzaki Y, Gyotoku J, Ogawa M, Nishikawa S, Katsura Y, Gachelin G, Nakauchi H: Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J Exp Med 178:1283, 1993.
26. Ardavin C, Wu L, Li CL, Shortman K: Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 362:761, 1993.
27. Shortman K, Vremec D, Corcoran LM, Georgopoulos K, Lucas K, Wu L: The linkage between T-cell and dendritic cell development in the mouse thymus. Immunol Rev 165:39, 1998.
28. Martin P, del Hoyo GM, Anjuere F, Ruiz SR, Arias CF, Marin AR, Ardavin C: Concept of lymphoid versus myeloid dendritic cell lineages revisited: Both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors. Blood 96:2511, 2000.
29. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, Weissman IL: Development of CD8alphapositive dendritic cells from a common myeloid progenitor. Science 290:2152, 2000.
30. Martinez del Hoyo G, Martin P, Arias CF, Marin AR, Ardavin C: CD8alpha+ dendritic cells originate from the CD8alpha-dendritic cell subset by a maturation process involving CD8alpha, DEC-205, and CD24 up-regulation. Blood 99:999, 2002.
31. del Hoyo GM, Martin P, Vargas HH, Ruiz S, Arias CF, Ardavin C: Characterization of a common precursor population for dendritic cells. Nature 415:1043, 2002.
32. Res PC, Couwenberg F, Vyth-Dreese FA, Spits H: Expression of pTalpha mRNA in a committed dendritic cell precursor in the human thymus. Blood 94:2647, 1999.
33. Bendriss-Vermare N, Barthelemy C, Durand I, Bruand C, Dezutter-Dambuyant C, Moulian N, Berrih-Aknin S, Caux C, Trinchieri G, Briere F: Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest 107:835, 2001.
34. Heemskerk MH, Blom B, Nolan G, Stegmann AP, Bakker AQ, Weijer K, Res PC, Spits H: Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med 186:1597, 1997.
35. Blom B, Heemskerk MH, Verschuren MC, van Dongen JJ, Stegmann AP, Bakker AQ, Couwenberg F, Res PC, Spits H: Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loophelix protein Id3 in committed T cell progenitors. Embo J 18:2793, 1999.
36. Jaleco AC, Stegmann AP, Heemskerk MH, Couwenberg F, Bakker AQ, Weijer K, Spits H: Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3. Blood 94:2637, 1999.
37. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH: Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med 192:1775, 2000.
38. Pulendran B, Banchereau J, Burkeholder S, Kraus E, Guinet E, Chalouni C, Caron D, Maliszewski C, Davoust J, Fay J, Palucka K: Flt3-ligand and granulocyte colonystimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 165:566, 2000.
39. Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, Hoek J, Caron D, Lebsack ME, McKenna HJ: In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96:878, 2000.
40. Nikolic T, Dingjan GM, Leenen PJ, Hendriks RW: A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur J Immunol 32:686, 2002.
41. Nakano H, Yanagita M, Gunn MD: CD11c(+)B220(+) Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 194:1171, 2001.
42. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, Vicari A, O'Garra A, Biron C, Briere F, Trinchieri G: Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2:1144, 2001.
43. Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu XL, Trinchieri G, O'Garra A, Liu YJ: The development of murine plasmacytoid dendritic cell precursors is differentially regulated by Flt3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 195:953, 2002.
44. Bjorck P: Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98:3520, 2001.
45. Spits H, Blom B, Jaleco AC, Weijer K, Verschuren MC, van Dongen JJ, Heemskerk MH, Res PC: Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev 165:75, 1998.
46. Spits H, Lanier LL, Phillips JH: Development of human T and natural killer cells. Blood 85:2654, 1995.
47. Shortman K, Wu L: Early T lymphocyte progenitors. Annu Rev Immunol 14:29, 1996.
48. Sprent J, Webb SR: Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 7:196, 1995.
49. Brocker T: The role of dendritic cells in T cell selection and survival. J Leukoc Biol 66:331, 1999.
50. Vandenabeele S, Hochrein H, Mavaddat N, Winkel K, Shortman K: Human thymus contains two distinct dendritic cell populations. Blood 97:1733, 2001.
51. Marquez C, Trigueros C, Fernandez E, Toribio ML: The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44. J Exp Med 181:475, 1995.
52. dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood 87:5196, 1996.
53. de Yebenes VG, Carrasco YR, Ramiro AR, Toribio ML: Identification of a myeloid intrathymic pathway of dendritic cell development marked by expression of the granulocyte macrophage-colony-stimulating factor receptor. Blood 99:2948, 2002.
54. Weijer K, Uittenbogaart CH, Voordouw A, Couwenberg F, Seppen J, Blom B, Vyth-Dreese FA, Spits H: Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood 99:2752, 2002.
55. Massari ME, Murre C: Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms. Mol Cell Biol 20:429, 2000.
56. Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C: E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 17:4782, 1997.
57. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, et al: E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885, 1994.
58. Zhuang Y, Soriano P, Weintraub H: The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875, 1994.
59. Bain G, Robanus Maandag EC, te Riele HP, Feeney AJ, Sheehy A, Schlissel M, Shinton SA, Hardy RR, Murre C: Both E12 and E47 allow commitment to the B cell lineage. Immunity 6:145, 1997.
60. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49, 1990.
61. Kim D, Peng XC, Sun XH: Massive apoptosis of thymocytes in T-cell-deficient Idl transgenic mice. Mol Cell Biol 19:8240, 1999.
62. Sun XH: Constitutive expression of the Idl gene impairs mouse B cell development. Cell 79:893, 1994.
63. Graves BJ, Petersen JM: Specificity within the ets family of transcription factors. Adv Cancer Res 75:1, 1998.
64. Wasylyk B, Hahn SL, Giovane A: The Ets family of transcription factors. Eur J Biochem 211:7, 1993.
65. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA: The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113, 1990.
66. Su GH, Ip HS, Cobb BS, Lu MM, Chen HM, Simon MC: The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J Exp Med 184:203, 1996.
67. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV: Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126:3131, 1999.
68. Galson DL, Hensold JO, Bishop TR, Schalling M, D'Andrea AD, Jones C, Auron PE, Housman DE: Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol Cell Biol 13:2929, 1993.
69. Chen HM, Zhang P, Voso MT, Hohaus S, Gonzalez DA, Glass CK, Zhang DE, Tenen DG: Neutrophils and monocytes express high levels of PU: 1 (Spi-1) but not Spi-B. Blood 85:2918, 1995.
70. Hromas R, Orazi A, Neiman RS, Maki R, Van Beveran C, Moore J, Klemsz M: Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82:2998, 1993.
71. Su GH, Chen HM, Muthusamy N, Garrett-Sinha LA, Baunoch D, Tenen DG, Simon MC: Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. Embo J 16:7118, 1997.
72. Scott EW, Simon MC, Anastasi J, Singh H: Requirement of transcription factor PU: 1 In the development of multiple hematopoietic lineages. Science 265:1573, 1994.
73. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA: Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. Embo J 15:5647, 1996.
74. DeKoter RP, Lee HJ, Singh H: PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16:297, 2002.
75. Dahl R, Ramirez-Bergeron DL, Rao S, Simon MC: Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. Embo J 21:2220, 2002.
76. Schotte R, Rissoan MC, Bendriss-Vermare N, Bridon JM, Duhen T, Weijer K, Brière F, Spits H: The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T, B, and NK cell development. Blood 2002 Sep 19; epub ahead of print.